The Results and Outcomes of Rectal Cancer Treatment in the Era of Adjuvant Chemoradiation
Abstract Background: Colorectal cancer causes many deaths worldwide and rectal cancer includes one-third of them. Surgical mesorectal excision along with preoperative neoadjuvant chemoradiotherapy is known as the standard treatment for rectal cancer. However, inaccurate preoperative staging is a mai...
Guardado en:
Autores principales: | Ahmad Izadpanah, Seyed Vahid Hosseini, Maytham Al-Qanbar, Mozhdeh Zamani, Behnam Kadkhodaei |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Shiraz University of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/16c9b98e942148fabb7f273492d970bf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinicopathological features, clinical efficacy on 101 cases of rectal gastrointestinal stromal tumors, and the significance of neoadjuvant therapy
por: Hongxin Yang, et al.
Publicado: (2021) -
Sarcopenia’s Prognostic Impact on Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
por: Donggun Lee, et al.
Publicado: (2021) -
Preoperative intensity-modulated chemoradiotherapy with simultaneous integrated boost in rectal cancer: five-year follow-up results of a phase II study
por: But-Hadzic Jasna, et al.
Publicado: (2021) -
Improvement in the Survival of Esophageal Cancer Patients at Cancer Institute of Iran after Implementation of the Neo-adjuvant Chemo-radiation: Retrospective Cohort Study
por: Saeed Nemati, et al.
Publicado: (2021) -
Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan
por: Hisanaga K, et al.
Publicado: (2021)